Representing a biotech company in the form of a foreign corporation, we carried out the foreign exchange transaction report and the establishment registration of a domestic corporation. By linking the remittance of capital from the home country with the schedule for establishing the domestic corporation, we completed the early stage of market entry without any omission in reporting or delay in procedures. Taking into account the characteristics of a research-and-development-focused company, we also examined intellectual property protection and the structure for future investment attraction.
This case has been de-identified to protect client confidentiality, and specific case outcomes and amounts are not stated. If you are reviewing a similar matter, we will guide you on how to proceed through a free consultation.